99 results
Page 5 of 5
424B5
ehbv07hye55n9tzp3
31 May 19
Prospectus supplement for primary offering
5:23pm
6-K
EX-99.1
kjnrx5nu
22 May 19
Sol-Gel Technologies Reports First Quarter 2019 Financial Results and Corporate Update
7:58am
6-K
EX-99.1
nn0slhwaf uarnn7vw
16 Apr 19
Current report (foreign)
8:25am
F-3/A
lri3vssoy8ot07jke
10 Apr 19
Shelf registration (foreign) (amended)
11:46am
F-3
0xg0pd00z ku9v
28 Mar 19
Shelf registration (foreign)
1:21pm
6-K
EX-99.1
icftubprm6s68xqf2
22 Mar 19
Current report (foreign)
8:00am
6-K
EX-99.1
m0ho4co
6 Feb 19
Sol-Gel and Perrigo will equally share the gross profits generated from sales of the product
4:01pm
6-K
EX-99.1
7x5rekr1bv2t
15 Jan 19
Sol-Gel Technologies Appoints John Vieira as U.S. Head of Commercialization
6:33am
6-K
EX-99.1
amd2v7b3nes
7 Jan 19
Current report (foreign)
6:32am
6-K
EX-99.1
jszhn
26 Dec 18
Sol-Gel Technologies Initiates Pivotal Phase III Clinical Program of TWIN for the Treatment of Acne Vulgaris
6:07am
6-K
EX-99.1
9t1lciye
4 Dec 18
Sol-Gel Technologies Announces Sixth Agreement for a Generic Product Candidate with Perrigo
4:05pm
6-K
EX-99.1
xryoxws4g fzox2y86
13 Nov 18
Sol-Gel Technologies Reports Third Quarter 2018 Financial Results
4:45pm
6-K
EX-99.1
xsalcr6pji02 kmo2loc
1 Nov 18
Sol-Gel Technologies Announces an Additional Collaborative Agreement for a Generic
4:04pm
6-K
EX-99.1
hybw7poi8j
15 Aug 18
Sol-Gel Technologies Announces Collaborative Agreement for Generic Product with Perrigo
4:01pm
6-K
EX-99.1
s5yl5262oujgvvfw
8 Aug 18
Sol-Gel Technologies Reports Second Quarter 2018 Financial Results
7:05am
6-K
EX-99.1
3uqk8bi
19 Jun 18
Current report (foreign)
8:54am
6-K
EX-99.1
daja j9ey
15 May 18
Sol-Gel Technologies Reports First Quarter 2018 Financial Results
12:00am
20-F
s0wpiwdm8l0i4o
26 Mar 18
Annual report (foreign)
12:00am